Topic starter
14/08/2026 6:34 pm
TL;DR: Healthcare teams that handle PHI cannot treat SOC 2 as the end state because HIPAA becomes a legal obligation the moment PHI is created, received, maintained, or transmitted, and HHS has proposed stricter Security Rule requirements for 2026, according to Drata. The sequencing problem is real: HIPAA first, then the right HITRUST tier, because control maturity matters more than buying extra assurance too early.
Editorial analysis by NHI Mgmt Group, based on content published by Drata: “Post-SOC 2 Playbook for Healthcare: Building Your HIPAA and HITRUST Roadmap”.
By the numbers:
- HITRUST e1 covers roughly 44 controls, runs $35,000 to $50,000, and carries a one-year validity.
- HITRUST i1 covers around 182 controls, runs $70,000 to $120,000, and is the tier most health plan and hospital system contracts actually mean when they say "HITRUST required."
- HITRUST r2 scores 200-plus controls against maturity, runs $100,000 to $500,000 or more, and carries a two-year certification with a required interim assessment at year one.
Key questions
Q: What breaks when a healthcare team treats SOC 2 as the end state after handling PHI?
A: The team can end up with strong assurance evidence but weak legal alignment.
Q: How should healthcare teams choose between HIPAA and HITRUST for access control?
A: They should not treat them as substitutes.
Q: What do security teams get wrong about HITRUST tiers?
A: They often assume the most demanding tier is automatically the right one.
Practitioner guidance
- Map PHI flows end to end Inventory every workflow where PHI enters, moves through, or leaves the environment, including subprocessors and partner integrations.
- Treat HIPAA as the baseline control set Map existing SOC 2 evidence to HIPAA Privacy, Security, and Breach Notification obligations, then document the missing administrative safeguards.
- Confirm the exact HITRUST tier in contract language Validate whether the buyer requires e1, i1, or r2 before scoping assessment work or estimating cost and timing.
Bottom line: SOC 2 can support healthcare assurance, but it does not displace HIPAA once PHI is in scope.
Explore further
View Full Forum → | NHI Foundation Course → | Our Services → | Read the full analysis →
14/08/2026 6:41 pm
HIPAA, not SOC 2, defines the real compliance floor for healthcare workflows handling PHI. SOC 2 can validate security discipline, but it does not itself create the legal obligations that arise once PHI enters scope. That distinction matters because governance teams often confuse buyer assurance with regulatory compliance. The correct model is to treat SOC 2 as supporting evidence, not as the compliance endpoint.
A few things that frame the scale:
- 60% of healthcare organisations do not assess a vendor's security before signing a contract that grants access to protected health information, according to Ponemon Institute's 2023 Third-Party Risk in Healthcare report.
A question worth separating out:
Q: Which controls should healthcare teams prepare for in the proposed HIPAA Security Rule?
A: They should expect stronger baseline expectations around multifactor authentication, encryption of ePHI at rest and in transit, and tighter breach reporting discipline. The practical test is whether those controls are already operational and evidenced, not whether they are simply planned for a future compliance cycle.
👉 Read our full editorial: Healthcare post-SOC 2 compliance now starts with HIPAA